Who Paid My Doc
A Phase 1 Study of Sgnb6a in Advanced Solid Tumors
Research payments
$7,847,465
Through program year 2025, $7,847,465 in research payments was reported against A Phase 1 Study of Sgnb6a in Advanced Solid Tumors, across 391 payments, paid by Pfizer Inc..
- Paid by
- Pfizer Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,965,370 | 215 |
| 2024 | Research | $4,882,095 | 176 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Cesar Batista Orlando, FL Named on 69 payments
- Edwin Kingsley Las Vegas, NV Named on 32 payments
- Kartik Sehgal Boston, MA Named on 27 payments
- Richard Zuniga Babylon, NY Named on 21 payments
- Steven Powell Sioux Falls, SD Named on 18 payments
- Alexander Spira Fairfax, VA Named on 15 payments
- Siddhartha Devarakonda Seattle, WA Named on 15 payments
- Abdul Rafeh Naqash Oklahoma City, OK Named on 13 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.